In summary, SLPI exerts renoprotective effects in AKI by attenuating inflammation, e.g., by suppressing CCL2 and TNF-α, reducing neutrophil infiltration, and promoting tubular epithelial cell repair, potentially via modulating macrophage polarization of inhibiting M1 phenotype and the NF-κB pathway. Here, TNF is linked to acute kidney injury.